Abeona Therapeutics ABEO
NASDAQ ABEO
$2.60 +0.18 (+7.44%)
At close: Nov 16, 2026 · 4:00 PM EST

Abeona Therapeutics (ABEO) Return on Capital Employed [ROCE] (2014 - 2026)

Updated

Abeona Therapeutics (ABEO) posted Return on Capital Employed [ROCE] of -49.05% for Q3 2026, down 10.61 percentage points from -38.44% a year earlier but up 1.87 percentage points from the prior quarter.

Analysis

Abeona Therapeutics (ABEO) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends

For FY2025, Abeona Therapeutics' Return on Capital Employed [ROCE] came in at -66.41%, up 25.47 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -10.39 percentage points (FY2020 to FY2025).
  • In prior years, Abeona Therapeutics' Return on Capital Employed [ROCE] was -91.89% in FY2024 (+1.11 pp), -92.99% in FY2023 (-13.59 pp), -79.40% in FY2022 (+11.55 pp) and -90.96% in FY2021 (-34.93 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -290.43% in Q3 2022 to a high of -38.44% in Q3 2025 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in seven of the last eight quarters, with an average year-over-year change of +12.50 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2023, with a gain of 199.27 percentage points; the weakest was Q3 2022, with a drop of 231.81 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -50.92% (Q2 2026), -52.11% (Q1 2026) and -45.69% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 17.52%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 21.60%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 4.65%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 9.91%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 17.37%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -6.15%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 11.32%
10 Abeona Therapeutics 149.28 Mn -492.16 Mn 7.78 Mn -49.05%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -49.05%
Jun 30, 2026 -50.92%
Mar 31, 2026 -52.11%
Dec 31, 2025 -45.69%
Sep 30, 2025 -38.44%
Jun 30, 2025 -53.90%
Mar 31, 2025 -80.79%
Dec 31, 2024 -65.40%
Sep 30, 2024 -55.80%
Jun 30, 2024 -64.79%
Mar 31, 2024 -85.92%
Dec 31, 2023 -91.31%
Sep 30, 2023 -91.16%
Jun 30, 2023 -102.05%
Mar 31, 2023 -82.48%
Dec 31, 2022 -116.49%
Sep 30, 2022 -290.43%
Jun 30, 2022 -248.54%
Mar 31, 2022 -174.10%
Dec 31, 2021 -108.66%
API Access

Abeona Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ABEO&period=max&api_key=YOUR_API_KEY